Downers Grove, IL – Coventry recently released part two of the 2019 edition of its Annual Drug Trends Series Report.
In part two of its workers’ compensation drug trends series, Coventry provides analysis on the trends experienced within its combined in-network and out-of-network channels to address the total view of prescription activity.
As with part one of the series where Coventry evaluated retail and mail-order prescriptions, in part two both out-of-network prescription utilization and cost rose slightly from 2018.
Some highlights from the report include:
- Generic efficiency increased 0.3% points from 96.0% in 2018 to 96.3%
- 7 of the top 10 therapeutic classes by cost were also in the top 10 for utilization
- Opioids were the only therapeutic class of the top 10 that experienced decreased utilization and cost per claim
Each part in the series is accompanied by an ongoing deeper dive into various related topics to address the specific trends highlighted in the infographics.
View the report: Coventry 2019 Workers’ Compensation Drug Trends Series Part 2
Coventry is a WorkCompWire ad partner.
This is not a paid placement.